Neuropsychiatry
April 1, 2011
Peter Bieling
3 citations
Mindfulness-based cognitive therapy (MBCT) is still a relatively new, standalone treatment for the prevention of relapse in depression. Combining about equal parts of mindfulness (Vipassana) meditation and cognitive behavioral principles, the treatment is 8 weeks of 2 h sessions for a group of remitted participants that can range in size (8–15 would be typical).
Revista de Psicopatología y Psicología Clínica
April 1, 2011
María Teresa Miró, Lilisbeth Perestelo-Pérez, Jeanette Pérez Ramos et al.
27 citations
The aim of this study was to determine the degree of clinical effi cacy of mindfulness based treatments in the treatment of anxiety and/or depressive disorders, from a systematic review of relevant studies in the scientifi c literature. From a total of 1,450 references identifi ed, 15 studies met the selection criteria. Systematic analysis of these studies showed that interventions based on...
Fortschritte der Neurologie · Psychiatrie
April 2011
Georgios Paslakis, P Gass, Michael Deuschle
An increasing significance has been attributed to the glutamatergic system in the pathophysiology of affective disorders. Glutamate is the most important excitatory neurotransmitter in the central nervous system. Glia cells are crucial regulators of the glutamatergic metabolism. Several studies have reported a dysfunction or reduced number of glia cells in patients suffering from depression....
Journal of College Student Psychotherapy
March 31, 2011
Jaimie L. Burns, Randolph M. Lee, Lauren J. Brown
78 citations
The effects of meditation, specifically Transcendental Meditation (TM), on college students' experience of stress, anxiety, depression, and perfectionistic thoughts was investigated using 43 undergraduate students. Self-report measures of the variables were completed prior to the start of the study. Student groups were trained in TM and practiced the technique consistently over a two-semester...
Neuroscience
March 17, 2011
H Kamiyama, M Matsumoto, S Otani et al.
The non-competitive N-methyl-D-aspartate NMDA receptor antagonist ketamine, a dissociative anesthetic capable of inducing analgesia, is known to have psychotomimetic actions, but the detailed mechanisms remain unclear because of its complex properties. The present study elucidated neural mechanisms of the effect of ketamine, at doses that exert psychotomimetic effects without anesthetic and...
Journal of Psychiatry and Neuroscience
March 1, 2011
Simon N. Young
23 citations
A recent paper in the Archives of General Psychiatry confirms that mindfulness-based cognitive therapy (MBCT) “offers protection against relapse/recurrence on a par with that of maintenance antidepressant pharmacotherapy.”[1][1] It is a tribute to the accumulated wisdom of humankind that a
European Psychiatry
March 1, 2011
Helen Murphy, Marika Lahtinen
NICE guidelines indicate one in five people will suffer from depression at some point in their lives with relapse rates of 50–80% in those who have experienced one or more episodes of depression (National Institute for Health and Clinical Excellence [NICE], 2007). By 2020, depression is predicted to be the second largest cause of death or disability and consequently there is a need to explore...
ANU Open Research
2011
Lauren Clare Wood
1 citation
Mindfulness-based Cognitive Therapy (MBCT) is a class-based manualised program designed to treat recurrent depression and prevent relapse. MBCT has been found to be effective for both symptomatic and asymptomatic patients with three or more previous episodes of depression. While research estimates that 50 - 75% of individuals with depression also experience anxiety, the role of anxiety in the...
Addiction Biology
2011
Increased effects of 3,4-methylenedioxymethamphetamine (ecstasy) in a rat model of depression.
eCommons
2011
Isaac Yitzhak Taitz
15 citations
The present study tested two hypotheses: 1) that lucid dreaming could be effectively taught through an online intervention, and 2) that lucid dreaming can alleviate depression as mediated by LOC. Surveys consisting of (lucid) dream frequency and recall scales (Schredl & Erlacher, 2004; Doll, Gitter, & Holzinger, 2009), Rotter’s LOC scale (1966), and the most recent Beck Depression Index...